BC-DXI-843

BC-DXI-843 is AIMP2-DX2 inhibitor. It as a promising lead for development of novel therapeutics targeting AIMP2-DX2 in lung cancer.

Product information

CAS Number: 2421117-98-6

Molecular Weight: 546.66

Formula: C28H26N4O4S2

Synonym:

BCDXI 843

BCDXI843

BCDXI-843

BC-DXI-843

BC-DXI843

BC-DXI 843

Chemical Name: (S)-3-(1H-Indol-3-yl)-N-(4-(4-methoxyphenyl)thiazol-2-yl)-2-(4-methylphenylsulfonamido)propanamide

Smiles: CC1C=CC(=CC=1)S(=O)(=O)N[C@@H](CC1=CNC2=CC=CC=C12)C(=O)NC1=NC(=CS1)C1C=CC(=CC=1)OC

InChiKey: VLPGAOXBMXGNGM-VWLOTQADSA-N

InChi: InChI=1S/C28H26N4O4S2/c1-18-7-13-22(14-8-18)38(34,35)32-25(15-20-16-29-24-6-4-3-5-23(20)24)27(33)31-28-30-26(17-37-28)19-9-11-21(36-2)12-10-19/h3-14,16-17,25,29,32H,15H2,1-2H3,(H,30,31,33)/t25-/m0/s1

Technical Data

Appearance: Solid Power.

Purity: ≥98% (or refer to the Certificate of Analysis)

Solubility: Soluble in DMSO

Shipping Condition: Shipped under ambient temperature as non-hazardous chemical or refer to Certificate of Analysis

Storage Condition: Dry, dark and -20 ^oC for 1 year or refer to the Certificate of Analysis.

Shelf Life: ≥12 months if stored properly.

Stock Solution Storage: 0 - 4 ^oC for 1 month or refer to the Certificate of Analysis.

Drug Formulation: To be determined.

HS Tariff Code: 382200

References:

1. Aneesh Sivaraman, Dae Gyu Kim, Deepak Bhattarai, Minkyoung Kim, Hwa Young Lee, Semi Lim, Jiwon Kong, Ja-il GooSeunghwan Shim, Seungbeom Lee, Young-Ger Suh,Yongseok Choi, Sunghoon Kim, Kyeong Lee. Synthesis and Structure–Activity Relationships of Arylsulfonamides as AIMP2-DX2 Inhibitors for the Development of a Novel Anticancer Therapy. J. Med. Chem. 2020. doi: 10.1021/acs.jmedchem.9b01961.

Products are for research use only. Not for human use.